AusCann Group Holdings Ltd (AC8.AX)

0.0400 0.0000 (0.00%) At close: 05:10PM AEDT

AusCann Group Holdings Ltd

35 Havelock Street
Level 4
West Perth, WA 6005
Australia
61 8 9426 8999
https://auscann.com.au

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Christopher Mews A.C.I.S., ACIS, B. Bus, C.P.A., CPA	CFO & Director	50k	N/A	N/A
Mr. Layton Patrick Mills	Exec. Officer	302.5k	N/A	N/A
Dr. Margaret Curtis	Head of R&D	241.58k	N/A	N/A
Ms. Susan Patricia Park A.C.A., A.C.I.S., ACA, ACIS, ACSA, AGIA, B.Com., B	Company Sec.	N/A	N/A	1975

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

Corporate governance

AusCann Group Holdings Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.